StonvexLoading…
StonvexStonvexStonvexCore line items from ZLAB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $457.18M | $397.61M | $266.72M | $212.67M |
Operating Income | $-229.43M | $-282.12M | $-366.57M | $-404.36M |
Net Income | $-175.54M | $-257.10M | $-334.62M | $-443.29M |
EPS (Diluted) | $-0.16 | $-0.26 | $-0.35 | $-0.46 |
Total Assets | $1.17B | $1.19B | $1.04B | $1.22B |
Total Liabilities | $456.88M | $344.86M | $240.18M | $174.54M |
Cash & Equivalents | $679.57M | $449.67M | $790.15M | $1.01B |
Free Cash Flow OCF − CapEx | $-158.89M | $-220.53M | $-205.39M | $-392.23M |
Shares Outstanding | 1.11B | 1.08B | 972.24M | 960.22M |